Brief: Active Biotech Q2 operating loss 23.1 mln SEK
10/08/2017 07:32
Aug 10 (Reuters) - Active Biotech Ab ACTI.ST
* Active biotech ab q2 operating loss 23.1 million sek
* Active biotech ab q2 sales 5.1 million sek
Source text for Eikon: ID:nGNE8k0FMD
Further company coverage: ACTI.ST
(Reporting By Anna Ringstrom)
((Anna.Ringstrom@thomsonreuters.com;))
Recent news on Active Biotech AB publ
See all newsBrief: Active Biotech Says Japan Grants Patent For Laquinimod Ophthalmic Formulation
Brief: Active Biotech Reports Q2 Operating Profit Of SEK -10.2 Mln
Brief: Active Biotech Expands U.S. Collaboration
Brief: Active Biotech Gets Approval To Resume Enrolment In Hovon 172 MF Study
Brief: Active Biotech Q1 Loss After Tax At SEK 8.4 Million